Aivodx (Ivosidenib) 250mg Tablets — IDH1 Inhibitor Generic for AML | Laos | GLT

Generic Information: Aivodx (Ivosidenib) — Laos Generic

Aivodx is the generic ivosidenib product of BigBear Pharmaceutical (Lao) Co., Ltd., registered with the Lao drug authority under registration number 12L1054/23. Each bottle contains 30 film-coated tablets of 250 mg — a convenient monthly-format pack for ivosidenib's once-daily schedule. As a generic of the originator Tibsovo, Aivodx delivers the same active ingredient, the same 250 mg strength, and the same mechanism of action, at a cost level that keeps this rare-mutation therapy within reach for patients in regions where the originator is unaffordable or simply unavailable.

BigBear is one of Laos' most export-oriented oncology generic manufacturers, with a growing portfolio of oral targeted agents shipped across Southeast Asia, South Asia, and the Middle East under GMP manufacturing discipline.

What Is Aivodx (Ivosidenib) 250 mg?

Aivodx tablets each contain 250 mg of ivosidenib, matching the originator's core strength exactly. The pack design — 30 tablets per bottle — mirrors a full month of therapy at one tablet per day, which simplifies adherence tracking for patients and inventory planning for pharmacies. The product is manufactured and released in Laos with batch-level quality control, and every carton carries the Lao registration number and manufacturer details required for cross-border verification.

How Does Aivodx (Ivosidenib) Work?

Ivosidenib inhibits the mutant IDH1 enzyme, the metabolic engine behind 2-hydroxyglutarate (2-HG) accumulation in a subset of acute myeloid leukemia and bile-duct cancer patients. By shutting down 2-HG production, the drug lifts the differentiation block that keeps leukemic cells immature, allowing them to mature and self-destruct naturally. This targeted, metabolism-correcting mechanism distinguishes ivosidenib from every cytotoxic and signaling-directed AML therapy and makes it active precisely in the patients whose tumors test IDH1-positive.

Indications for Aivodx

• Relapsed or refractory acute myeloid leukemia (AML) with a susceptible IDH1 mutation, as confirmed by validated mutation testing.
• Newly diagnosed IDH1-mutated AML in older or less fit adults in combination regimens, mirroring the originator's evidence base where local practice supports it.
• IDH1-mutated cholangiocarcinoma beyond first-line therapy, at the treating oncologist's discretion.

Dosage of Aivodx 250 mg Tablets

The standard regimen is one 250 mg tablet once daily, swallowed whole at the same time each day, with or without food — but never alongside a high-fat meal and never split or crushed. Therapy continues until progression or unacceptable toxicity. As with the originator, patients need baseline and follow-up ECG monitoring for QTc, serial blood counts, and vigilance for differentiation syndrome, which responds to corticosteroids when treated early. Physicians individualize dose holds and reductions according to the prescribing guidance.

Side Effects of Ivosidenib (Aivodx)

The safety profile matches the originator molecule: expect possible fatigue, low white-cell counts, diarrhea, swelling of ankles, nausea, vomiting, mouth sores, abdominal discomfort, and QTc prolongation on ECG. The two medically serious risks — differentiation syndrome and significant QT prolongation — are well characterized, monitorable, and manageable with early intervention. Regular laboratory review and open communication with the treating hematologist are part of responsible therapy with any ivosidenib product.

Storage of Aivodx Bottles

Store below 30°C in the original tightly closed container, away from moisture and direct sunlight. No refrigeration is needed. Keep all medicines out of children's reach, and discard expired bottles through a pharmacy take-back program where available.

Why Choose Aivodx Generic Ivosidenib?

For most of the world's IDH1-mutated AML patients, the originator's Western pricing puts continuous daily therapy out of reach. Aivodx closes that gap: same molecule, same strength, same once-daily routine — supplied by a GMP-certified Lao manufacturer at a small fraction of the originator's cost. GIVE LIFE TIME LIMITED (GLT) verifies BigBear's registration and batch documentation for every order, so hospital buyers and families receive genuine product rather than an unverified copy.

How to Order Aivodx from Laos

To order Aivodx (ivosidenib 250 mg, 30 tablets per bottle) from BigBear Pharmaceutical, contact GIVE LIFE TIME LIMITED (GLT). We supply institutional buyers — hospital procurement, licensed pharmacy wholesalers, physician buyers — as well as individual patients. Message us on WhatsApp at +86 15234153837 or email [email protected] for current availability, documentation, and shipping arrangements.

FAQ: Aivodx (BigBear Ivosidenib)

Q: Is Aivodx the same drug as Tibsovo?
A: Yes — Aivodx contains the same 250 mg ivosidenib tablet as the originator, produced by BigBear Pharmaceutical in Laos.

Q: How many tablets come in a bottle?
A: Aivodx is packed 30 tablets per bottle — a full month at the once-daily dose.

Q: Is Aivodx registered anywhere?
A: It holds Lao registration number 12L1054/23, printed on the carton for verification.

Q: What does Aivodx treat?
A: IDH1-mutated acute myeloid leukemia, and in some settings IDH1-mutated cholangiocarcinoma, at the oncologist's judgment.

Q: How do I order?
A: Contact GLT on WhatsApp +86 15234153837 or email [email protected] for pricing and delivery details.